S&P 500   3,942.56 (+0.66%)
DOW   32,161.22 (+0.94%)
QQQ   305.05 (-0.10%)
AAPL   157.40 (+1.55%)
MSFT   271.03 (-3.01%)
META   197.04 (+0.73%)
GOOGL   101.13 (-0.48%)
AMZN   97.02 (-1.95%)
TSLA   183.32 (+1.77%)
NVDA   258.58 (+0.52%)
NIO   8.67 (+4.96%)
BABA   80.72 (-1.16%)
AMD   96.06 (-1.82%)
T   18.44 (+1.71%)
F   11.19 (-0.97%)
MU   57.18 (+0.92%)
CGC   1.88 (-6.00%)
GE   89.88 (-0.45%)
DIS   93.67 (+0.50%)
AMC   4.30 (+2.87%)
PFE   40.59 (+1.22%)
PYPL   72.56 (-0.59%)
NFLX   303.66 (+0.05%)
S&P 500   3,942.56 (+0.66%)
DOW   32,161.22 (+0.94%)
QQQ   305.05 (-0.10%)
AAPL   157.40 (+1.55%)
MSFT   271.03 (-3.01%)
META   197.04 (+0.73%)
GOOGL   101.13 (-0.48%)
AMZN   97.02 (-1.95%)
TSLA   183.32 (+1.77%)
NVDA   258.58 (+0.52%)
NIO   8.67 (+4.96%)
BABA   80.72 (-1.16%)
AMD   96.06 (-1.82%)
T   18.44 (+1.71%)
F   11.19 (-0.97%)
MU   57.18 (+0.92%)
CGC   1.88 (-6.00%)
GE   89.88 (-0.45%)
DIS   93.67 (+0.50%)
AMC   4.30 (+2.87%)
PFE   40.59 (+1.22%)
PYPL   72.56 (-0.59%)
NFLX   303.66 (+0.05%)
S&P 500   3,942.56 (+0.66%)
DOW   32,161.22 (+0.94%)
QQQ   305.05 (-0.10%)
AAPL   157.40 (+1.55%)
MSFT   271.03 (-3.01%)
META   197.04 (+0.73%)
GOOGL   101.13 (-0.48%)
AMZN   97.02 (-1.95%)
TSLA   183.32 (+1.77%)
NVDA   258.58 (+0.52%)
NIO   8.67 (+4.96%)
BABA   80.72 (-1.16%)
AMD   96.06 (-1.82%)
T   18.44 (+1.71%)
F   11.19 (-0.97%)
MU   57.18 (+0.92%)
CGC   1.88 (-6.00%)
GE   89.88 (-0.45%)
DIS   93.67 (+0.50%)
AMC   4.30 (+2.87%)
PFE   40.59 (+1.22%)
PYPL   72.56 (-0.59%)
NFLX   303.66 (+0.05%)
S&P 500   3,942.56 (+0.66%)
DOW   32,161.22 (+0.94%)
QQQ   305.05 (-0.10%)
AAPL   157.40 (+1.55%)
MSFT   271.03 (-3.01%)
META   197.04 (+0.73%)
GOOGL   101.13 (-0.48%)
AMZN   97.02 (-1.95%)
TSLA   183.32 (+1.77%)
NVDA   258.58 (+0.52%)
NIO   8.67 (+4.96%)
BABA   80.72 (-1.16%)
AMD   96.06 (-1.82%)
T   18.44 (+1.71%)
F   11.19 (-0.97%)
MU   57.18 (+0.92%)
CGC   1.88 (-6.00%)
GE   89.88 (-0.45%)
DIS   93.67 (+0.50%)
AMC   4.30 (+2.87%)
PFE   40.59 (+1.22%)
PYPL   72.56 (-0.59%)
NFLX   303.66 (+0.05%)
OTCMKTS:LZAGY

Lonza Group - LZAGY Stock Forecast, Price & News

$57.40
-0.41 (-0.71%)
(As of 03/17/2023 08:55 PM ET)
Add
Compare
Today's Range
$56.78
▼
$57.61
50-Day Range
$49.79
▼
$60.93
52-Week Range
$43.85
▼
$73.53
Volume
53,800 shs
Average Volume
133,204 shs
Market Capitalization
$42.75 billion
P/E Ratio
N/A
Dividend Yield
0.16%
Price Target
N/A

Lonza Group MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
26.55%
From $1.77 to $2.24 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.26 out of 5 stars

See Top Rated MarketRank™ Stocks Here

LZAGY stock logo

About Lonza Group (OTCMKTS:LZAGY) Stock

Lonza Group AG is engaged in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules segment offers small molecule drug substances and intermediates related services. The Cell and Gene segment includes the Cell and Gene Technologies and Bioscience businesses. The Capsule and Health Ingredients segment provides innovative capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies. The Corporate segment refers to finance and accounting, legal, communication, information technology, and human resources functions. The company was founded on October 27, 1897 and is headquartered in Basel, Switzerland.

Receive LZAGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lonza Group and its competitors with MarketBeat's FREE daily newsletter.

LZAGY Stock News Headlines

March 17, 2023 | forbes.com
Lonza Group
February 20, 2023 | investing.com
Citi Reiterates Buy Rating on Lonza Group AG
March 20, 2023 | Weiss Ratings (Ad)
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
February 16, 2023 | finance.yahoo.com
The Petri Dish: Blueprint hit with clinical hold, Moderna to set up patient assistance program
January 26, 2023 | finance.yahoo.com
Lonza Group Full Year 2022 Earnings: EPS Beats Expectations
January 25, 2023 | seekingalpha.com
Lonza Group AG (LZAGY) Q4 2022 Earnings Call Transcript
January 25, 2023 | finance.yahoo.com
UPDATE 2-European stocks fall on earnings jitters, rate hike worries
January 25, 2023 | finance.yahoo.com
European stocks fall on earnings jitters, rate hike worries
March 20, 2023 | Weiss Ratings (Ad)
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
January 25, 2023 | finance.yahoo.com
UPDATE 2-Lonza to buy back $2.17 bln worth of shares, backs mid-term growth
January 25, 2023 | finance.yahoo.com
Lonza to buy back $2.17 billion worth of shares, backs mid-term growth
December 10, 2022 | finance.yahoo.com
Institutions along with individual investors who hold considerable shares inLonza Group AG (VTX:LONN) come under pressure; lose 9.3% of holdings value
November 23, 2022 | finance.yahoo.com
With EPS Growth And More, Lonza Group (VTX:LONN) Makes An Interesting Case
November 19, 2022 | seekingalpha.com
LZAGY Lonza Group AG
November 2, 2022 | finance.yahoo.com
Lonza Group's (VTX:LONN) five-year total shareholder returns outpace the underlying earnings growth
October 26, 2022 | bizjournals.com
Swiss biotech giant Lonza Group AG eyes big Emeryville lease with Longfellow
September 6, 2022 | markets.businessinsider.com
Lonza and Touchlight collaborate on end-to-end mRNA offering
July 22, 2022 | finance.yahoo.com
Lonza's first-half core EBITDA gains 16.5%
July 22, 2022 | finance.yahoo.com
UPDATE 1-Lonza's first-half core EBITDA gains 16.5%
June 18, 2022 | seekingalpha.com
Lonza: One Stop Shop For Global Drug Manufacturing, At A Price
March 10, 2022 | seekingalpha.com
Lonza finishes laboratory expansion at API manufacturing facility in China
January 29, 2022 | seekingalpha.com
Lonza Group AG GAAP EPS of CHF39.52, revenue of CHF5.4B
January 27, 2022 | finance.yahoo.com
HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate
January 26, 2022 | ca.finance.yahoo.com
Lonza's full-year core EBITDA up 20.7% on vaccine demand
January 19, 2022 | nasdaq.com
Lonza Group AG ADR (LZAGY)
November 13, 2021 | finance.yahoo.com
Should You Have Lonza Stock on Your Watchlist?
July 27, 2021 | finance.yahoo.com
Moderna Slips As Issues At Partners Delay Overseas Release Of Shots
See More Headlines
Receive LZAGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lonza Group and its competitors with MarketBeat's FREE daily newsletter.

LZAGY Company Calendar

Today
3/20/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Tobacco products
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:LZAGY
CUSIP
N/A
CIK
1446711
Web
www.lonza.com
Phone
(161) 316-8111
Fax
41-61-316-9111
Employees
16,218
Year Founded
1897

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.15
Current Ratio
1.86
Quick Ratio
1.27

Sales & Book Value

Annual Sales
$6.52 billion
Price / Sales
6.55
Cash Flow
$1.44 per share
Price / Cash Flow
39.99
Book Value
$15.01 per share
Price / Book
3.82

Miscellaneous

Outstanding Shares
744,690,000
Free Float
744,167,000
Market Cap
$42.75 billion
Optionable
Not Optionable
Beta
0.99

Social Links


Key Executives

  • Pierre-Alain Ruffieux
    Chief Executive Officer
  • Maria Soler Nunez
    Head-Group Operations
  • Philippe Deecke
    Chief Financial Officer
  • Dirk Oehlers
    Investor Relations Officer
  • Caroline Barth
    Chief Human Resources Officer

Key Competitors

View All Competitors













LZAGY Stock - Frequently Asked Questions

Should I buy or sell Lonza Group stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lonza Group in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LZAGY shares.
View LZAGY analyst ratings or view top-rated stocks.

How have LZAGY shares performed in 2023?

Lonza Group's stock was trading at $48.75 at the beginning of the year. Since then, LZAGY shares have increased by 17.7% and is now trading at $57.40.
View the best growth stocks for 2023 here.

Are investors shorting Lonza Group?

Lonza Group saw a increase in short interest in February. As of February 28th, there was short interest totaling 8,900 shares, an increase of 50.8% from the February 13th total of 5,900 shares. Based on an average daily trading volume, of 604,700 shares, the short-interest ratio is currently 0.0 days.
View Lonza Group's Short Interest.

How often does Lonza Group pay dividends? What is the dividend yield for Lonza Group?

Lonza Group declared a dividend on Wednesday, May 4th. Shareholders of record on Tuesday, May 10th will be given a dividend of $0.0895 per share on Thursday, May 26th. This represents a yield of 0.39%. The ex-dividend date is Monday, May 9th.
Read our dividend analysis for LZAGY.

Is Lonza Group a good dividend stock?

Lonza Group (OTCMKTS:LZAGY) pays an annual dividend of $0.09 per share and currently has a dividend yield of 0.15%.
Read our dividend analysis for LZAGY.

What is Lonza Group's stock symbol?

Lonza Group trades on the OTCMKTS under the ticker symbol "LZAGY."

How do I buy shares of Lonza Group?

Shares of LZAGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lonza Group's stock price today?

One share of LZAGY stock can currently be purchased for approximately $57.40.

How much money does Lonza Group make?

Lonza Group (OTCMKTS:LZAGY) has a market capitalization of $42.75 billion and generates $6.52 billion in revenue each year.

How many employees does Lonza Group have?

The company employs 16,218 workers across the globe.

Does Lonza Group have any subsidiaries?
The following companies are subsidiares of Lonza Group: Arch Acquisition LLC, Arch Chemicals Canada Inc., Arch Chemicals Inc., Arch Chemicals Limited, Arch Chemicals Receivables LLC, Arch Chemicals SAS, Arch Personal Care Products L.P., Arch Protection Chemicals Private Limited, Arch Quimica Argentina S.R.L., Arch Quimica Brasil Ltda., Arch Timber Protection B.V., Arch Treatment Technologies Inc., Arch UK Biocides Limited, Arch Water Products France S.A.S., Arch Water Products South Africa (Pty) Ltd, Arch Wood Protection (Aust) Pty Ltd, Arch Wood Protection (M) Sdn. Bhd., Arch Wood Protection (NZ) Limited, Arch Wood Protection (SA) Pty Ltd, Arch Wood Protection Canada Corp., Arch Wood Protection Inc, Bend Research Inc., BioAtrium AG, CH Capsules Malaysia SDN BHD, Capsugel, Capsugel (Thailand) Co. Ltd, Capsugel Australia Pty Ltd, Capsugel Belgium NV, Capsugel Brasil Importação e Distribuição de Insumos Farmacêuticos e Alimentos Ltda., Capsugel Canada Corp., Capsugel Distribucion S. de R.L. de C.V., Capsugel FinanceCo II S.à r.l., Capsugel FinanceCo S.C.A., Capsugel FinanceCo S.à r.l, Capsugel France Holdings SAS, Capsugel France SAS, Capsugel Funding LLC, Capsugel Germany GmbH, Capsugel Healthcare Private Limited, Capsugel Holdings (Hong Kong) Limited, Capsugel Holdings S.à r.l., Capsugel Holdings US Inc., Capsugel Hungary Kft, Capsugel Inc., Capsugel Italy S.R.L., Capsugel Japan Inc., Capsugel Manufacturing Inc., Capsugel Middle East Sàrl, Capsugel New Zealand Limited, Capsugel Pharmaceutical and Health Products Marketing Ltd, Capsugel Philippines Inc., Capsugel Ploermel SAS, Capsugel S.à r.l., Capsugel Spain S.L., Capsugel US LLC, Capsugel de México S. de R.L. de C.V., Diacon Technologies, Diacon Technologies Limited, Hickson Ltd, InterHealth Nutraceuticals, InterHealth Nutraceuticals Incorporated, LLC Capsugel, Lonza (China) Investments Co. Ltd., Lonza AG, Lonza America Inc., Lonza Argentina S.A, Lonza Biologics Inc., Lonza Biologics Porriño S.L., Lonza Biologics Tuas Pte. Ltd, Lonza Biologics plc, Lonza Bioscience SARL, Lonza Bioscience Singapore Pte Ltd, Lonza Biotec s.r.o., Lonza Cologne GmbH, Lonza Colombia S.A.S, Lonza Copenhagen ApS, Lonza Costa Rica S.A., Lonza Geleen B.V., Lonza Guangzhou Ltd, Lonza Guangzhou Nansha Ltd, Lonza Houston Inc., Lonza Inc., Lonza India Private Limited, Lonza Israel Ltd, Lonza Japan Ltd, Lonza Luxembourg S.à r.l., Lonza Microbial Control Asia Pacific Pte Ltd, Lonza Milano S.r.l., Lonza NZ Limited, Lonza Nanjing Ltd, Lonza Netherlands B.V, Lonza Rockland Inc., Lonza Sales AG, Lonza Shanghai International Trading Ltd, Lonza Suzhou Ltd, Lonza Swiss Finanz AG, Lonza Swiss Licences AG, Lonza Verviers SPRL, Lonza Walkersville Inc., Lonza do Brasil Especialidades Quimicas Ltda., MW Encap (Holdings) Limited, MW Encap Limited, Micro-Macinazione, Micro-Macinazione SA, Octane Biotech, Octane Biotech Inc, P.T. Capsugel Indonesia, PharmaCell, Powdersize LLC, Suzhou Capsugel Limited (JV), Triangle Research Labs, Xcelience Clinical Services Ltd, Xcelience LLC, and Zelam Holdings.
Read More
How can I contact Lonza Group?

Lonza Group's mailing address is Muenchensteinerstrasse 38, Basel V8, 4002. The official website for the company is www.lonza.com. The company can be reached via phone at (161) 316-8111, via email at investor.relations@lonza.com, or via fax at 41-61-316-9111.

This page (OTCMKTS:LZAGY) was last updated on 3/20/2023 by MarketBeat.com Staff